Greenwich LifeSciences, Inc.

NASDAQ:GLSI

9.98 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -15.789-8.892-7.825-4.571-1.863-3.425-1.69-1.573
Depreciation & Amortization 0.0040.0040.0040.0040.0040.0040.0040.004
Deferred Income Tax 00-1.751-1.195-0.778000
Stock Based Compensation 7.2532.3781.7440.6610.6780.19500
Change In Working Capital 1.2650.032-0.122-0.3850.0282.9331.5711.449
Accounts Receivables 00000000
Inventory 00000000
Accounts Payables 0.9210.0350-0.527-0.0930.3930.0810.145
Other Working Capital 0.344-0.004-0.1220.1420.1212.541.491.304
Other Non Cash Items 001.7511.1950.778-0-0.074-0.138
Operating Cash Flow -7.267-6.479-6.2-4.292-1.153-0.293-0.115-0.121
Investing Activities:
Investments In Property Plant And Equipment 00000000
Acquisitions Net 00000000
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites 00000000
Investing Cash Flow 00000000
Financing Activities:
Debt Repayment 00000000
Common Stock Issued 4.369003.11130.16700.10
Common Stock Repurchased 00-7.5360000-0.09
Dividends Paid 00000000
Other Financing Activities 4.369002.835-0.360.2150.2-0.13
Financing Cash Flow 4.3690-7.5362.83529.8070.2150.2-0.13
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash -2.897-6.479-13.736-1.45628.654-0.0780.085-0.251
Cash At End Of Period 4.0926.98913.46827.20428.660.0070.0850